Dabrafenib and Trametinib Administration in Patients with BRAF V600E/R or Non-V600 BRAF Mutated Advanced Solid Tumours (BELIEVE, NCCH1901): a Multicentre, Open-Label, and Single-Arm Phase II Trial.
ECLINICALMEDICINE(2024)
Key words
Bayesian statistics,Platform clinical trials,BRAF inhibitors,MEK inhibitors,Rare cancers
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined